Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Helen Reeves BMBS, PhD, FRCP

Helen Reeves BMBS, PhD, FRCP

Professor of Liver Cancer, Newcastle University Translational and Clinical Research Institute, Newcastle University, Newcastle-upon-Tyne NHS Foundation Trust, Newcastle upon Tyne, United Kingdom

Helen Reeves graduated from Nottingham Medical school in 1990, moving shortly afterwards to Newcastle-upon-Tyne. There she trained as a gastroenterologist and secured a Wellcome Trust Clinical Training fellowship, completing a PhD studying cell signalling pathways in liver fibrosis. She then moved to Mount Sinai Medical School in New York, funded by an AASLD fellowship, studying the molecular pathogenesis of cancers with Professor Scott Friedman. She returned to the UK in 2003, having won a GlaxoSmithKline Senior Fellowship. Presently she is Professor of Liver Cancer in the Newcastle University Centre for Cancer and is the clinical lead for the care of patients with hepatocellular carcinoma in North East England and Cumbria.  She has been a scientific committee member for the British Association for Cancer Research and the European Association for Study of the Liver. She is an active member of the HCC-UK Committee. Her main research focus is on HCC in patients with NAFLD and in the development of clinically relevant biomarkers and therapeutic targets. She has a program grant from CRUK centred on exploring the roles of neutrophils in HCC.  She is also the PI for the Liver Cancer focused Accelerator award, jointly funded by CRUK, FC AECC and AIRC entitled ‘HUNTER: Hepatocellular Carcinoma Expediter Network’.


Dr. Reeves has no relevant disclosures.